TB-500 + BPC-157 (Wolverine) 20 mg

Synthetic Peptides — Tissue Repair Research

In plain terms: These two peptides are studied together for their roles in how tissue

repairs itself — cell migration, blood flow, and collagen formation are the main research

threads.

Compound classification: TB-500 and BPC-157 are synthetic peptides studied in the

context of tissue repair, angiogenesis, and cellular regeneration research.

Studied mechanism: TB-500 has been studied for a role in actin regulation and cellular

migration relevant to tissue remodeling. BPC-157 has been studied in relation to VEGF

and nitric oxide signaling pathways connected to blood flow and collagen synthesis.

Research findings: Available research (predominantly preclinical) has examined wound

healing, tendon/ligament recovery, and inflammatory markers. Standardized research

protocols for these compounds are still evolving.

Effects reported in research literature:

Mild injection site irritation (in study subjects)

Temporary fatigue

Research status: Most supporting data is preclinical; human research protocols remain

under development.

Research Use Only: This compound is intended for laboratory research use only. It is

not a drug, dietary supplement, or consumer product, and is not for human or animal

consumption. Statements have not been evaluated by the FDA and are not intended to

diagnose, treat, cure, or prevent any disease.